RxDoctor Payments Data

Harris Greenberger, DPM

Foot & Ankle Surgery · Norwalk, CTNPI 1023019619

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $2,193 of the $2,984 with a category attached, or 73.5%. 19 manufacturers reported payments, led by Treace Medical Concepts, Inc. at 41.8% of the total. 2025 is the largest year on record at $1,356, 2.2 times the $606 reported in 2019.

$2,984in general payments, 2019–2025

Across 80 payments — averaging $37.31 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Treace Medical Concepts, Inc.$1K
  • Smith+Nephew$292
  • Organogenesis Inc.$263
  • Sandoz$254
  • Sebela Pharmaceuticals Inc.$233
  • Curonix LLC$147
  • plus $549 from 13 others

What the payments were for

  • Travel & lodging$76626%
  • Food & beverage$2,19373%
  • Education$251%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$2,984 in reported general payments places this provider in the 55th percentile of 89 foot & ankle surgery providers in Connecticut.

See all foot & ankle surgery providers in Connecticut

Medicare billing

Part B allowed, 2024
$1,125,017
Medicare patients
188
Services billed
1,202

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Gabapentin24$683
Ciclopirox15$578
CiclopiroxCiclopirox Olamine24$553
Econazole Nitrate12$350
Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav23$291
Ammonium Lactate17$215
Meloxicam11$42

Paid to pharmacies, not to this prescriber.

Other foot & ankle surgery in Norwalk

See the full list for Connecticut

Where these figures come from

Is this you, or does something look wrong? →